Increased Incidence of Central Venous Catheter-Related Infection in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy

Waters, Peadar S; Smith, Andrew W.; Fitzgerald, E; Khan, Fatima; Moran, Brendan; Shields, Conor; Lynch, Breda; O’Loughlin, C.; Lynch, Maureen; Mulsow, Jürgen

doi:10.1089/sur.2018.250

Cited by 6 publications

(11 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Study design varied with the most common type using a retrospective design. We included nine retrospective study designs, [15][16][17][18][19][20][21][22][23] four guidelines, [24][25][26][27] two prospective design studies, 14,28 two literature reviews, 11,29 one survey, 30 one case study 31 and one cross sectional analysis. 32 Among the reports included, no randomised control trials (RCTs), no systematic reviews, no meta-analysis or meta-synthesis and no scoping reviews were identified.…”

Section: Characteristics Of Sources Of Evidencementioning

confidence: 99%

“…The most common research questions examined by the reports were infection of VADs with 30% (n = 6) of them being related to this topic, 15,17,20,23,24,28 25% (n = 5) reported on the care and maintenance of VADs for Health Care…”

Section: Characteristics Of Sources Of Evidencementioning

confidence: 99%

“…To also monitor rates of peripheral intravenous cannula adverse events and blood culture contamination rates before and after the changeover of doctors Practitioners (HCPs), 14,21,25,26,27 20% (n = 4) reported on complications associated with VADs, 11,22,29,32 10% (n = 2) reported on complications of a peripherally inserted central catheter (PICC) in haematology patients, 16,19 10% (n = 2) reported on education for parents of paediatric patients 18,30 and 5% (n = 1) reported on VAD choice by the patient. 31 Our review on sample sizes found that two sample sizes were not specified, 28,30 six sample sizes were not applicable, 11,[24][25][26][27]29 four sample sizes had under 50 patients, 14,17,21,31 three had sample sizes between 50 and 100 patients, 15,19,23 one was between 100 and 500 patients, 16 two were between 500 and 1000 patients 18,20 and two were over 1000 patients. 22,32 We found no evidence of study protocol publication and no study was registered as a clinical trial.…”

Section: Funding Not Mentionedmentioning

confidence: 99%

“…Twelve of the studies were single hospital site only. 14,[16][17][18][19][20][21][22][23]28,30,32 Of the 20 reports 5 15,[24][25][26][27] were funded by health service authorities such as the Health Service Executive (HSE), Health Protection Surveillance Centre (HPSC), NCCP and Guidelines and Audit Implementation Network (GAIN).…”

Section: Funding Not Mentionedmentioning

confidence: 99%

“…• • CVC infection rates were 10.9 per 1000 line days before the non-consultant hospital doctors (NCHD) changeover and 1.5 per 1000 line days afterwards Implications for future research. Eight of the studies did not mention recommendations for future research, 14,16,[18][19][20]23,30,31 as displayed in Table 2. Two of the included guidelines did not give a schedule for review and update.…”

Section: Funding Not Mentionedmentioning

confidence: 99%

See 4 more Smart Citations

A scoping review of Clinical Studies, Hospital Group Reports and National Strategic Documents on vascular access devices in cancer patients

2021

View full text Add to dashboard Cite

Introduction: The extent of vascular/venous access device (VAD) research output from the Island of Ireland is unknown. The identification of the papers available is important to create a future research agenda. Objectives: The main objective of this study is to answer three questions: What is the number and descriptive quality of reported Vascular Access Device literature from the Island of Ireland? Is the reporting of Catheter Related Infection rates for cancer patients common in Irish Hospital Groups, National Cancer Reports and Publication Outputs? What are the implications for future research in this area? Methods: We used a scoping review and searched selected databases, grey literature and hospital regulatory bodies websites following the Joanna Briggs Institute Guidelines 2017. A data charting form was developed based on a template from the Joanna Briggs Institute and this was used to extract data from the included reports. Results: A total of 660 reports were screened. Sixty-one full text articles were reviewed from which 20 reports were included for data extraction. Of the reports included the following designs were used: nine retrospective study designs, four guidelines, two prospective study designs, two literature reviews and one of the following; survey, case study and cross sectional analysis designs. We did not identify any randomised controlled trials, systematic reviews, meta-analysis, meta-synthesis and scoping reviews. Five studies included catheter related infection rates. Gaps in the research include the collection of data sets and the need to establish a VAD registry; develop core outcomes for VADs; assessment and evaluation of VAD care bundles among cancer patients; and, the inclusion of public and patient involvement in future VAD research. Conclusion: The reporting of VAD outcomes in published literature regarding cancer patients receiving treatment in Ireland is inconsistent and varied with no interventional studies addressing vascular access complications in cancer care.

show abstract